Marcia Kauer-SantAnna
Overview
Explore the profile of Marcia Kauer-SantAnna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
2370
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anzolin A, Baldez D, Montezano B, Kapczinski F, de Abreu P, Kauer-SantAnna M
Psychiatry Res
. 2024 Apr;
337:115915.
PMID: 38688118
This investigation explores the efficacy of subcutaneous ketamine for mitigating depressive symptoms and suicidal ideation, addressing a crucial need for rapid-onset treatments in severe depression cases. It introduces an innovative...
2.
Gnielka V, Montezano B, Baldez D, Shintani A, Rabelo-da-Ponte F, Menezes A, et al.
Braz J Psychiatry
. 2024 Feb;
46:e20233338.
PMID: 38343357
Objective: Bipolar disorder (BD) is a major cause of disability-adjusted life years in young adults. Pregnancy complications have previously been associated with BD. The current study aimed to examine the...
3.
Bristot G, Feiten J, Pfaffenseller B, Hizo G, Possebon G, Valiati F, et al.
Trends Psychiatry Psychother
. 2024 Jan;
PMID: 38219212
Objectives: To evaluate relative expression of genes with the potential to translate environmental stimuli into long-term alterations in the brain - namely Early Growth Response (EGR)1, EGR3, and Cryptochrome Circadian...
4.
Pinto J, Crippa J, Cereser K, Vianna-Sulzbach M, Silveira Junior E, Santana da Rosa G, et al.
Can J Psychiatry
. 2023 Nov;
69(4):242-251.
PMID: 37920963
Objective: The treatment of bipolar depression remains challenging due to the limited effective and safe therapeutic options available; thus, developing newer treatments that are effective and well tolerable is an...
5.
Anzolin A, Goularte J, Pinto J, Belmonte-de-Abreu P, Cruz L, Cordova V, et al.
Front Psychiatry
. 2023 Mar;
14:1147298.
PMID: 36970275
Background: Psychiatric disorders are associated with more than 90% of reported suicide attempts worldwide, but few treatments have demonstrated a direct effect in reducing suicide risk. Ketamine, originally an anesthetic,...
6.
Valiati F, Feiten J, Gea L, Silveira Junior E, Scotton E, Caldieraro M, et al.
Trends Psychiatry Psychother
. 2022 Dec;
45:e20220576.
PMID: 36527709
Background: Emerging evidence indicates that inflammation plays an important role as a mechanism underlying mental disorders. However, most of the research on inflammatory mechanisms focuses on serum levels of interleukins...
7.
Fijtman A, Clausen A, Kauer-SantAnna M, Morey R
J Psychiatr Res
. 2022 Dec;
157:119-126.
PMID: 36463626
Objectives: Veterans are at increased risk for exposure to trauma, developing serious mental illnesses, and death by suicide. History of trauma correlates with worsening outcomes in patients with bipolar disorder....
8.
Shintani A, Rabelo-da-Ponte F, Marchionatti L, Watts D, Ferreira de Souza F, Machado C, et al.
Neurosci Biobehav Rev
. 2022 Nov;
144:104960.
PMID: 36375585
Background: Perinatal and prenatal risk factors may be implicated in the development of bipolar disorder, but literature lacks a comprehensive account of possible associations. Methods: We performed a systematic review...
9.
Anzolin A, Feiten J, Bristot G, Possebon G, Fleck M, Caldieraro M, et al.
Psychiatry Res
. 2022 Jun;
314:114601.
PMID: 35749859
Major depressive disorder (MDD) is a common condition that affects the general population over a wide range of ages, regardless of gender and social background. Early-onset of MDD in adulthood,...
10.
Fijtman A, Felder P, Passos I, Kauer-SantAnna M
Lancet Psychiatry
. 2021 Nov;
8(12):1039.
PMID: 34801127
No abstract available.